Revolutionizing Stroke Treatment with Robotics
Remedy Robotics has been selected as the exclusive robotics partner for Mission Thrombectomy, enhancing access to essential stroke treatments globally. This partnership will utilize Remedy's pioneering N1 System to implement remote robotic technology in thrombectomy procedures.
Strategic Collaboration for Better Outcomes
This collaboration ensures that stroke patients around the world receive timely and effective treatment. Remedy Robotics will work closely with the Mission Thrombectomy network, which is comprised of clinical experts in over 100 countries. Their joint efforts will streamline the integration of robotic technology into existing medical workflows for stroke treatment.
Fulfilling a Critical Need in Healthcare
Stroke remains one of the leading causes of disability and death worldwide, making immediate access to advanced treatment crucial. Through this partnership, Remedy Robotics and Mission Thrombectomy aim to ensure that geographic barriers do not prevent patients from receiving life-saving thrombectomy procedures.
Expert Insights
Dr. David Bell, CEO of Remedy Robotics, expressed excitement about the partnership, noting, "This collaboration will help make endovascular intervention more accessible to patients everywhere. By working hand-in-hand with Mission Thrombectomy’s esteemed clinicians, we can enhance the safety and accessibility of thrombectomy procedures worldwide."
Commitment to Global Health
Mission Thrombectomy’s Global Chair, Dr. Fawaz Al-Muft, emphasizes the importance of this collaboration by stating, "Our mission is to guarantee that no patient’s access to recovery depends on their location." This partnership is set to bridge gaps in healthcare access and improve outcomes for stroke patients regardless of where they are located.
About Remedy Robotics
Remedy Robotics is dedicated to revolutionizing cardiovascular care through innovative robotic solutions. Their advanced technology empowers healthcare professionals to conduct complex life-saving procedures more effectively and safely, ensuring that patients receive the best care possible, wherever they may be.
About Mission Thrombectomy
Mission Thrombectomy is committed to improving stroke systems of care worldwide. By promoting awareness and understanding the importance of timely treatment for strokes, they advocate for better access to endovascular thrombectomy for patients everywhere.
Frequently Asked Questions
What is the purpose of the partnership between Remedy Robotics and Mission Thrombectomy?
The partnership aims to expand access to endovascular thrombectomy for stroke treatment using innovative robotic technology.
What is the N1 System?
The N1 System is Remedy Robotics' cutting-edge platform designed for remotely operated endovascular procedures, enhancing the efficiency and effectiveness of stroke treatments.
How will this collaboration benefit stroke patients?
By improving access to life-saving thrombectomy procedures, this collaboration will help ensure that more stroke patients receive timely and appropriate care, regardless of their location.
Who are the key figures in this partnership?
Dr. David Bell, the CEO of Remedy Robotics, and Dr. Fawaz Al-Muft, Global Chair of Mission Thrombectomy, are instrumental in driving this collaboration forward.
What is endovascular thrombectomy?
Endovascular thrombectomy is a minimally invasive procedure that involves the removal of clots from blood vessels in the brain, critical for treating acute ischemic strokes.
